Hawaii Interdisciplinary Mentored Career Development in HIV Co-Morbidities

摘要 夏威夷大学 联系MPI：Cecilia Shikuma，医学博士 这项关于在艾滋病毒相关领域建立夏威夷辅导机构职业发展方案的建议， 响应RFA-HL-18-006的心、肺、血液和睡眠（HLBS）共同发病研究由以下人员提交： 夏威夷艾滋病中心（Hawaii Center for AIDS），位于约翰A.夏威夷大学伯恩斯医学院 马诺阿（UHM）。我们建议在该领域培养下一代具有国家竞争力的调查人员 通过建立在艾滋病毒相关的HLBS合并症的研究优势， 研究和我们的艾滋病毒临床，转化和实验室科学基础设施，并加强 通过与其他计划建立互利的合作关系， 机构职能体系这包括与JABSOM内部各部门以及我们的 心血管研究中心及其T32计划和我们学校的心脏病学奖学金计划。 我们提出了一个整体K12结构与多PI领导涉及艾滋病毒临床研究人员，实验室 一名艾滋病毒免疫学家和一名心血管研究员以及一个执行委员会和一个行政委员会。 协助实施辅导机构职业发展计划，并提供协助 一个咨询委员会。第一年的赠款将用于规划这一结构的细节。 随后，最少3名，最多5名初级学者将提供长达3年的 在艾滋病毒/高脂血症合并症研究领域，为研究独立性提供指导支持。

ABSTRACT University of Hawaii Contact MPI: Cecilia Shikuma, MD This proposal to establish the Hawaii Mentored Institutional Career Development Program in HIV-Related Heart, Lung, Blood and Sleep (HLBS) Co-Morbidity Research in response to RFA-HL-18-006 is submitted by the Hawaii Center for AIDS (HICFA) at the John A. Burns School of Medicine (JABSOM), University of Hawaii at Manoa (UHM). We propose to groom the next generation of nationally competitive investigators in the field of HIV HLBS research by building on HICFA's growing research strengths in HIV-related HLBS co-morbidities research and our HIV clinical, translational and laboratory science infrastructure, and strengthen the infrastructure by establishing mutually beneficial collaborative relationships with other programs and institutions. This includes internal collaborations with various departments within JABSOM as well as with our Center for Cardiovascular Research and its T32 program and our school's Cardiology Fellowship Program. We propose an overall K12 structure with multi-PI leadership involving a HIV clinical researcher, a laboratory HIV immunologist and a Cardiovascular researcher and an Executive Committee and an Administrative Assistant to assist in implementation of a mentored institutional career development program with assistance of an Advisory Committee. Year one of the grant will be spent in planning the details of this structure. Subsequently a minimum of 3 and maximum of 5 junior scholars will be provided with up to 3 years of mentored support towards research independence in the research area of HIV HLBS co-morbidities.